A Study on the Safety and Immune Response of Investigational mRNA Seasonal Flu/COVID-19 Combination Vaccine in Adults

Clinical trial NCT07464314 · RECRUITING

Trial details

NCT number: NCT07464314
Sponsor: GlaxoSmithKline
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Influenza, Human+COVID-19

Start date: 2026-03-09
Primary completion: 2026-12-03
Enrollment: 225

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.